CoChat

A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility

Open access
Andresen, Martin A., Boyd, Neil · 2010 · International Journal of Drug Policy
Cited by 154

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

BACKGROUND A supervised injection facility (SIF) has been established in North America: Insite, in Vancouver, British Columbia. The purpose of this paper is to conduct a cost-effectiveness and cost-benefit analysis of this SIF using secondary data gathered and analysed in 2008. In using these data we seek to determine whether the facility's prevention of infections and deaths among injecting drug users (IDUs) is of greater or lesser economic cost than the cost involved in providing this service - Insite - to this community. METHODS Mathematical modelling is used to estimate the number of new HIV infections and deaths prevented each year. We use the number of these new HIV infections and deaths prevented, in conjunction with estimated lifetime public health care costs of a new HIV infection, and the value of a life, in order to calculate an identifiable portion of the societal benefits of Insite. The annual costs of operating the SIF are used to measure the social costs of Insite. In using this information, we calculate cost-effectiveness and benefit-cost ratios for the SIF. RESULTS Through the use of conservative estimates, Vancouver's SIF, Insite, on average, prevents 35 new cases of HIV and almost 3 deaths each year. This provides a societal benefit in excess of $6 million per year after the programme costs are taken into account, translating into an average benefit-cost ratio of 5.12:1. CONCLUSION Vancouver's SIF appears to be an effective and efficient use of public health care resources, based on a modelling study of only two specific and measurable benefits-HIV infection and overdose death.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drugpo.2009.03.004

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 30

  1. Chen, 2006, Distribution of health care expenditures for HIV-infected patients, Clinical Infectious Diseases, 42, 1003, 10.1086/500453 · DOI · Paper page
  2. Coffin, 2003, Opiates, cocaine, and alcohol combinations in accidental drug overdose deaths in New York City 1990–98, Addiction, 98, 739, 10.1046/j.1360-0443.2003.00376.x · DOI · Paper page
  3. Cohen, 2004, Willingness-to-pay for crime control programs, Criminology, 42, 89, 10.1111/j.1745-9125.2004.tb00514.x · DOI · Paper page
  4. Davidson, 2003, Fatal heroin-related overdose in San Francisco, 1997–2000: A case for targeted intervention, Journal of Urban Health, 80, 261, 10.1093/jurban/jtg029 · DOI · Paper page
  5. Des Jarlais, 1992, International epidemiology among injecting drug users, AIDS, 6, 1053, 10.1097/00002030-199210000-00001 · doi:10.1097/00002030-199210000-00001
  6. Des Jarlais, 1996, HIV incidence among injecting drug users in New York City syringe-exchange programmes, Lancet, 348, 987, 10.1016/S0140-6736(96)02536-6 · DOI · Paper page
  7. Frei, 2000, Socioeconomic evaluation of heroin maintenance treatment final report, Vol. 2, 37
  8. Gold, 1997, Needle exchange programs: An economic evaluation of a local experience, Canadian Medical Association Journal, 157, 255
  9. Grover, 1993, A prospective study of direct health care costs of HIV infected adults in Canada [abstract PO-D28-4226], International Conference on AIDS, 9, 922
  10. Holtgrave, 1997, Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 16, 55, 10.1097/00042560-199709010-00009 · DOI · Paper page
  11. Holtgrave, 1998, Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, S133, 10.1097/00042560-199802001-00022 · DOI
  12. Jacobs, 1999, Cost effectiveness of Streetworks’ needle exchange program of Edmonton, Canadian Journal of Public Health, 90, 168, 10.1007/BF03404500 · doi:10.1007/bf03404500
  13. Kaplan, 1993, Let the needles to the talking! Evaluating the New Haven needle exchange, Interfaces, 23, 7, 10.1287/inte.23.1.7 · doi:10.1287/inte.23.1.7
  14. Kerr, 2005, Potential use of safer injecting facilities among injection drug users in Vancouver's downtown eastside, Canadian Medical Association Journal, 169, 759
  15. Kerr, 2006, Impact of a medically supervised safer injection facility on community drug use patterns: A before and after study, British Medical Journal, 332, 220, 10.1136/bmj.332.7535.220 · DOI
  16. Kerr, 2006, Drug-related overdoses within a medically supervised safer injection facility, International Journal of Drug Policy, 17, 436, 10.1016/j.drugpo.2006.05.008 · DOI
  17. Kimber, 2003, Drug consumption facilities: An update since 2000, Drug and Alcohol Review, 22, 227, 10.1080/095952301000116951 · DOI · Paper page
  18. Kimber, 2005, A survey of drug consumption rooms: Service delivery and perceived public health and amenity impact, Drug and Alcohol Review, 24, 21, 10.1080/09595230500125047 · DOI
  19. Kleinig, 2006, Thinking ethically about needle and syringe programs, Substance Use and Misuse, 41, 815, 10.1080/10826080600668670 · DOI
  20. Laufer, 2001, Cost-effectiveness of syringe exchanges as an HIV prevention strategy, Journal of Acquired Immune Deficiency Syndromes, 28, 273, 10.1097/00042560-200111010-00012 · doi:10.1097/00042560-200111010-00012
  21. Lert, 2007, Antiretroviral HIV treatment and care for injecting drug users: An evidence-based overview, International Journal of Drug Policy, 18, 255, 10.1016/j.drugpo.2007.05.002 · doi:10.1016/j.drugpo.2007.05.002
  22. Petrar, 2007, Injection drug users’ perceptions regarding use of a medically supervised safer injection facility, Addictive Behaviors, 32, 1088, 10.1016/j.addbeh.2006.07.013 · DOI
  23. Siegel, 1991, Bleach programs for preventing AIDS among IV drug users: Modelling the impact of HIV prevalence, American Journal of Public Health, 81, 1273, 10.2105/AJPH.81.10.1273 · DOI
  24. Tyndall, 2006, Attendance, drug use patterns, and referrals made from North America's first supervised injection facility, Drug and Alcohol Dependence, 83, 193, 10.1016/j.drugalcdep.2005.11.011 · DOI
  25. Tyndall, 2006, HIV seroprevalence along participants of a supervised injection facility in Vancouver, Canada, Harm Reduction Journal, 3, 36, 10.1186/1477-7517-3-36 · DOI
  26. Vlahov, 1998, The role of needle exchange programs in HIV prevention, Public Health Reports, 113, 75
  27. Watters, 1994, Syringe and needle exchange as HIV/AIDS prevention for injection drug users, Journal of the American Medical Association, 271, 115, 10.1001/jama.271.2.115 · doi:10.1001/jama.271.2.115 · Paper page
  28. Wood, 2001, Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help?, Canadian Medical Association Journal, 165, 405
  29. Wood, 2005, Factors associated with syringe sharing among users of a medically supervised safer injecting facility, American Journal of Infectious Diseases, 1, 50, 10.3844/ajidsp.2005.50.54 · DOI
  30. Wood, 2006, Attendance of supervised injecting facilities and use of detoxification services, New England Journal of Medicine, 354, 2512, 10.1056/NEJMc052939 · DOI · Paper page

Cited by

See all 154

Metadata

Authors
Andresen, M. A., & Boyd, N.
Venue
International Journal of Drug Policy
Publisher
Elsevier BV
Published
2010-01
Volume
21
Issue
1
Pages
70-76
ISSN
0955-3959 (ISSN-L)
OpenAlex
W2165639864
Cited by
154
References
2
FWCI
3.29
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility. https://app.cochat.ai/papers/10.1016/j.drugpo.2009.03.004
The paper
Andresen, M. A., & Boyd, N. (2010). A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility. International Journal of Drug Policy. https://doi.org/10.1016/j.drugpo.2009.03.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.